Mounjaro (tirzepatide) is the better alternative for diabetes management
Until official regulatory approval is granted, there is no approved maximum dose for clinical use
Identity and Contact Information of the Data Controller This privacy policy applies to all personal data processed by Sensilab d.o.o., with its registered office at Verovkova 55a, 1000 Ljubljana, Slovenia, , company registration number 2113732000, and Vision Healthcare Group, with its registered office at Grote Markt 41, 8500 Kortrijk, Belgium, company registration number BE 0685.849.188, acting as joint controllers under the GDPR (hereafter called 'Data Controller')
Therefore, diabetic patients with acromegaly could be treated with SGLT-2i, albeit caution is required for patients with uncontrolled disease
Consider an alternative drug treatment If your Aetna plan doesnt cover Jardiance, or if your copay or coinsurance is too high, talk to your healthcare provider